Ignite Creation Date:
2024-05-05 @ 11:22 AM
Last Modification Date:
2024-10-26 @ 9:03 AM
Study NCT ID:
NCT00003268
Status:
COMPLETED
Last Update Posted:
2013-08-02
First Post:
1999-11-01
Brief Title:
Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Sponsor:
Sidney Kimmel Cancer Center at Thomas Jefferson University
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Leukemia |
| DrugAgent Toxicity by TissueOrgan |
Keywords:
| Name | View |
|---|---|
| adult acute minimally differentiated myeloid leukemia M0 | View |
| untreated adult acute myeloid leukemia | View |
| adult acute monoblastic leukemia and acute monocytic leukemia M5 | View |
| adult acute erythroid leukemia M6 | View |
| adult acute myeloblastic leukemia without maturation M1 | View |
| adult acute myeloblastic leukemia with maturation M2 | View |
| adult acute myelomonocytic leukemia M4 | View |
| adult acute megakaryoblastic leukemia M7 | View |
| drugagent toxicity by tissueorgan | View |